Life Sciences Innovation Fund

An early-stage co-investment fund designed to support companies in the Life Sciences and Healthcare Technologies sectors related to human health. Its main objective is to address the unique challenges faced by life sciences entrepreneurs in moving innovative, capital-intensive projects from concept to commercialization. The fund aims to drive Canadian business development, economic growth, and scalable impact in key health-related areas such as cancer treatment, regenerative medicine, neuroscience, and medical technologies.

Key features and objectives:

• Provides up to $500,000 in early-stage risk capital to eligible companies.
• Supports scaling of made-in-Ontario health solutions for both domestic and global markets.
• Co-invests alongside angel and other investors to de-risk opportunities and help startups become investor and customer ready.
• Focuses on companies raising pre-seed or seed investments with total round sizes between $1 million and $5 million.
• Targets Ontario or Canadian incorporated for-profit companies headquartered in Ontario.
• Companies must have raised less than $3 million in third-party capital.

Application process:

• Interested companies express their interest by submitting an interest form to determine if LSIF is suitable for their business.
• Detailed fund guidelines are available for download, outlining eligibility and investment criteria.
• The fund works closely with portfolio companies and partners to maximize commercialization impact.

Overall, LSIF is tailored to support early-stage life sciences ventures in overcoming funding barriers and accelerating their path to market success.